Variants inHSD11B1gene modulate susceptibility to diabetes kidney disease and to insulin resistance in type 1 diabetes
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | MORI, Rosana Cristina | |
dc.contributor.author | SANTOS-BEZERRA, Daniele Pereira | |
dc.contributor.author | PELAES, Tatiana Souza | |
dc.contributor.author | ADMONI, Sharon Nina | |
dc.contributor.author | PEREZ, Ricardo Vessoni | |
dc.contributor.author | MONTEIRO, Maria Beatriz | |
dc.contributor.author | MACHADO, Cleide Guimaraes | |
dc.contributor.author | QUEIROZ, Marcia Silva | |
dc.contributor.author | MACHADO, Ubiratan Fabres | |
dc.contributor.author | CORREA-GIANNELLA, Maria Lucia | |
dc.date.accessioned | 2021-02-18T13:47:17Z | |
dc.date.available | 2021-02-18T13:47:17Z | |
dc.date.issued | 2021 | |
dc.description.abstract | Background and aim 11 beta-Hydroxysteroid dehydrogenase 1 has been implicated in insulin resistance (IR) in the setting of metabolic disorders, and single nucleotide polymorphisms (SNPs) in its encoding gene (HSD11B1) have been associated with type 2 diabetes and metabolic syndrome. In type 1 diabetes (T1D), IR has been related to the development of chronic complications. We investigated the association ofHSD11B1SNPs with microvascular complications and with IR in a Brazilian cohort of T1D individuals. Materials and methods Five SNPs were genotyped in 466 T1D individuals (57% women; median of 37 years old, diabetes duration of 25 years and HbA1c of 8.4%). Results The minor allele T of rs11799643 was nominally associated with diabetic retinopathy (OR = 0.52; confidence interval [CI] 95% = 0.28-0.96;P= .036). The minor allele C of rs17389016 was nominally associated with overt diabetic kidney disease (DKD) (OR = 1.90; CI 95% = 1.07-3.37;P= .028). A follow-up study revealed that 29% of the individuals lost >= 5 mL min(-1)x 1.73 m(2)per year of the estimated glomerular filtration rate (eGFR). In these individuals (eGFR decliners), C allele of rs17389016 was more frequent than in non-decliners (OR = 2.10; CI 95% = 1.14-3.89;P= .018). Finally, minor allele T of rs846906 associated with higher prevalence of arterial hypertension, higher body mass index and waist circumference, thus conferring risk to a lower estimated glucose disposal rate, a surrogate marker of insulin sensitivity (OR = 1.23; CI 95% = 1.06-1.42;P= .004). Conclusion SNPs in theHSD11B1gene may confer susceptibility to DKD and to IR in T1D individuals. | eng |
dc.description.index | MEDLINE | eng |
dc.description.sponsorship | Coordenacao de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES [001] | |
dc.description.sponsorship | Fundacao de Amparo a Pesquisa do Estado de Sao PauloFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2016/15603-0] | |
dc.identifier.citation | DIABETES-METABOLISM RESEARCH AND REVIEWS, v.37, n.1, article ID e3352, 9p, 2021 | |
dc.identifier.doi | 10.1002/dmrr.3352 | |
dc.identifier.eissn | 1520-7560 | |
dc.identifier.issn | 1520-7552 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/39435 | |
dc.language.iso | eng | |
dc.publisher | WILEY | eng |
dc.relation.ispartof | Diabetes-Metabolism Research and Reviews | |
dc.rights | restrictedAccess | eng |
dc.rights.holder | Copyright WILEY | eng |
dc.subject | diabetic microvascular complications | eng |
dc.subject | estimated glomerular filtration rate (eGFR) | eng |
dc.subject | estimated glucose disposal rate (eGDR) | eng |
dc.subject | rs17389016 | eng |
dc.subject | rs846906 | eng |
dc.subject | single nucleotide polymorphism (SNP) | eng |
dc.subject.other | 11-beta-hydroxysteroid dehydrogenase type-1 | eng |
dc.subject.other | metabolic syndrome | eng |
dc.subject.other | gene polymorphisms | eng |
dc.subject.other | glomerular-filtration | eng |
dc.subject.other | genomic ancestry | eng |
dc.subject.other | association | eng |
dc.subject.other | complications | eng |
dc.subject.other | expression | eng |
dc.subject.other | obesity | eng |
dc.subject.other | 11-beta-hsd1 | eng |
dc.subject.wos | Endocrinology & Metabolism | eng |
dc.title | Variants inHSD11B1gene modulate susceptibility to diabetes kidney disease and to insulin resistance in type 1 diabetes | eng |
dc.type | article | eng |
dc.type.category | original article | eng |
dc.type.version | publishedVersion | eng |
dspace.entity.type | Publication | |
hcfmusp.author.external | MORI, Rosana Cristina:Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Ave Prof Lineu Prestes 1524, BR-05508900 Sao Paulo, Brazil | |
hcfmusp.author.external | PEREZ, Ricardo Vessoni:Univ Sao Paulo, Hosp Clin HCFMUSP, Lab Carboidratos & Radioimunoensaios LIM 18, Fac Med, Sao Paulo, Brazil | |
hcfmusp.author.external | MACHADO, Ubiratan Fabres:Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Ave Prof Lineu Prestes 1524, BR-05508900 Sao Paulo, Brazil | |
hcfmusp.citation.scopus | 7 | |
hcfmusp.contributor.author-fmusphc | DANIELE PEREIRA DOS SANTOS BEZERRA | |
hcfmusp.contributor.author-fmusphc | TATIANA SOUZA PELAES | |
hcfmusp.contributor.author-fmusphc | SHARON NINA ADMONI | |
hcfmusp.contributor.author-fmusphc | MARIA BEATRIZ CAMARGO MONTEIRO CAILLAUD | |
hcfmusp.contributor.author-fmusphc | CLEIDE GUIMARAES MACHADO CARANI | |
hcfmusp.contributor.author-fmusphc | MARCIA SILVA QUEIROZ | |
hcfmusp.contributor.author-fmusphc | MARIA LUCIA CARDILLO CORREA GIANNELLA | |
hcfmusp.description.articlenumber | e3352 | |
hcfmusp.description.issue | 1 | |
hcfmusp.description.volume | 37 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.pubmed | 32453474 | |
hcfmusp.origem.scopus | 2-s2.0-85087212103 | |
hcfmusp.origem.wos | WOS:000541435200001 | |
hcfmusp.publisher.city | HOBOKEN | eng |
hcfmusp.publisher.country | USA | eng |
hcfmusp.relation.reference | Andrews CA, 2010, NATURE ED KNOWL, V3, P65 | eng |
hcfmusp.relation.reference | Barat P, 2013, DIABETES METAB, V39, P163, DOI 10.1016/j.diabet.2012.10.001 | eng |
hcfmusp.relation.reference | Bjornstad P, 2015, WORLD J DIABETES, V6, P8, DOI 10.4239/wjd.v6.i1.8 | eng |
hcfmusp.relation.reference | Chapman K, 2013, PHYSIOL REV, V93, P1139, DOI 10.1152/physrev.00020.2012 | eng |
hcfmusp.relation.reference | Chiodini I, 2007, DIABETES CARE, V30, P83, DOI 10.2337/dc06-1267 | eng |
hcfmusp.relation.reference | Danielson KK, 2010, DIABETES CARE, V33, P614, DOI 10.2337/dc09-1220 | eng |
hcfmusp.relation.reference | Devang N, 2017, DIABETES RES CLIN PR, V131, P142, DOI 10.1016/j.diabres.2017.07.011 | eng |
hcfmusp.relation.reference | Draper N, 2005, J ENDOCRINOL, V186, P251, DOI 10.1677/joe.1.06019 | eng |
hcfmusp.relation.reference | Dujic T, 2012, BIOCHEM MEDICA, V22, P76 | eng |
hcfmusp.relation.reference | Duran-Gonzalez J, 2011, ARCH MED RES, V42, P523, DOI 10.1016/j.arcmed.2011.10.010 | eng |
hcfmusp.relation.reference | Feldman K, 2012, STEROIDS, V77, P1345, DOI 10.1016/j.steroids.2012.08.014 | eng |
hcfmusp.relation.reference | Gambineri A, 2011, EUR J ENDOCRINOL, V165, P283, DOI 10.1530/EJE-11-0091 | eng |
hcfmusp.relation.reference | Gandhi K, 2013, METAB SYNDR RELAT D, V11, P397, DOI 10.1089/met.2013.0049 | eng |
hcfmusp.relation.reference | Gathercole LL, 2010, J STEROID BIOCHEM, V122, P21, DOI 10.1016/j.jsbmb.2010.03.060 | eng |
hcfmusp.relation.reference | Gong R, 2008, LIFE SCI, V82, P631, DOI 10.1016/j.lfs.2007.12.019 | eng |
hcfmusp.relation.reference | Grolmusz VK, 2014, MOL BIOL REP, V41, P5961, DOI 10.1007/s11033-014-3473-2 | eng |
hcfmusp.relation.reference | Hejduk Paulina, 2015, Postepy Hig Med Dosw (Online), V69, P1245 | eng |
hcfmusp.relation.reference | Hunter RW, 2015, CURR OPIN PHARMACOL, V21, P105, DOI 10.1016/j.coph.2015.01.005 | eng |
hcfmusp.relation.reference | Kilpatrick ES, 2007, DIABETES CARE, V30, P707, DOI 10.2337/dc06-1982 | eng |
hcfmusp.relation.reference | Krolewski AS, 2017, KIDNEY INT, V91, P1300, DOI 10.1016/j.kint.2016.10.046 | eng |
hcfmusp.relation.reference | LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444 | eng |
hcfmusp.relation.reference | Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006 | eng |
hcfmusp.relation.reference | Lutz SZ, 2016, J CLIN ENDOCR METAB, V101, P4743, DOI 10.1210/jc.2016-2498 | eng |
hcfmusp.relation.reference | Montasser ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092468 | eng |
hcfmusp.relation.reference | Monteiro MB, 2016, FREE RADICAL RES, V50, P101, DOI 10.3109/10715762.2015.1109083 | eng |
hcfmusp.relation.reference | Nair S, 2004, DIABETOLOGIA, V47, P1088, DOI 10.1007/s00125-004-1407-6 | eng |
hcfmusp.relation.reference | Orchard TJ, 2002, KIDNEY INT, V62, P963, DOI 10.1046/j.1523-1755.2002.00507.x | eng |
hcfmusp.relation.reference | Pena SDJ, 2009, BRAZ J MED BIOL RES, V42, P870, DOI 10.1590/S0100-879X2009005000026 | eng |
hcfmusp.relation.reference | Pimenta JR, 2006, HUM HERED, V62, P190, DOI 10.1159/000096872 | eng |
hcfmusp.relation.reference | Pop A, 2016, J DIABETES, V8, P220, DOI 10.1111/1753-0407.12283 | eng |
hcfmusp.relation.reference | Quteineh L, 2015, PHARMACOGENET GENOM, V25, P246, DOI 10.1097/FPC.0000000000000131 | eng |
hcfmusp.relation.reference | Santos-Bezerra DP, 2018, DIABETES VASC DIS RE, V15, P81, DOI 10.1177/1479164117733918 | eng |
hcfmusp.relation.reference | Simunkova K, 2011, PHYSIOL RES, V60, P263, DOI 10.33549/physiolres.932079 | eng |
hcfmusp.relation.reference | STEWART PM, 1994, J CLIN ENDOCR METAB, V79, P480, DOI 10.1210/jc.79.2.480 | eng |
hcfmusp.relation.reference | Stomby A, 2014, DIABETOLOGIA, V57, P1100, DOI 10.1007/s00125-014-3228-6 | eng |
hcfmusp.relation.reference | Svensson M, 2002, EUR J CLIN INVEST, V32, P100, DOI 10.1046/j.1365-2362.2002.00949.x | eng |
hcfmusp.relation.reference | Tomlinson JW, 2001, BEST PRACT RES CL EN, V15, P61, DOI 10.1053/beem.2000.0119 | eng |
hcfmusp.relation.reference | Turek LV, 2014, GENET MOL BIOL, V37, P490, DOI 10.1590/S1415-47572014000400003 | eng |
hcfmusp.relation.reference | Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5 | eng |
hcfmusp.relation.reference | Williams KV, 2000, DIABETES, V49, P626, DOI 10.2337/diabetes.49.4.626 | eng |
hcfmusp.scopus.lastupdate | 2024-05-10 | |
relation.isAuthorOfPublication | 04b2d727-2bd6-469a-8d07-029d5bcf8d71 | |
relation.isAuthorOfPublication | 0ad56e25-b661-4e5a-9a8f-1b177356021b | |
relation.isAuthorOfPublication | 978f0307-9353-4ade-8202-4e566d38b896 | |
relation.isAuthorOfPublication | 595dcd98-4ca3-48b0-b904-063270ca9023 | |
relation.isAuthorOfPublication | 01eced4a-acb6-4768-90eb-92e8816ddc01 | |
relation.isAuthorOfPublication | 8f247733-75be-483d-a874-c2bdcd507ff9 | |
relation.isAuthorOfPublication | a816ae7a-8943-42d1-81f4-eeb39f544483 | |
relation.isAuthorOfPublication.latestForDiscovery | 04b2d727-2bd6-469a-8d07-029d5bcf8d71 |
Arquivos
Pacote Original
1 - 1 de 1
Nenhuma Miniatura disponível
- Nome:
- art_MORI_Variants_inHSD11B1gene_modulate_susceptibility_to_diabetes_kidney_disease_2021.PDF
- Tamanho:
- 699.55 KB
- Formato:
- Adobe Portable Document Format
- Descrição:
- publishedVersion (English)